United States PCR Molecular Diagnostics Market was valued at USD 4.12 Billion in 2022 and is projected to reach USD 8.35 Billion by 2030, growing at a CAGR of 10.2% from 2024 to 2030.
The US PCR Molecular Diagnostics Market has seen significant growth, driven by advancements in technology and the increasing demand for accurate diagnostic solutions. Polymerase chain reaction (PCR) is a molecular diagnostic technique widely used in healthcare, food safety, and environmental testing. It is especially crucial in identifying infectious diseases, genetic disorders, and in monitoring the effectiveness of treatments. With the rising need for rapid, non-invasive, and precise diagnostic methods, PCR-based testing has become integral across multiple industries.
One of the primary drivers of the PCR Molecular Diagnostics Market in the United States is the healthcare industry. Hospitals, clinics, and research laboratories rely heavily on PCR for diagnosing infectious diseases, including COVID-19, influenza, and various bacterial infections. The ability to detect minute quantities of pathogens has made PCR testing indispensable, particularly during outbreaks. According to recent studies, the demand for PCR testing surged dramatically during the COVID-19 pandemic, emphasizing its critical role in global health.
Moreover, the market is also influenced by the growing demand from the pharmaceutical industry. Pharmaceutical companies are increasingly utilizing PCR for drug development, genetic testing, and clinical trials. PCR allows for the accurate detection of mutations, gene expression profiling, and the analysis of genetic markers, which aids in the development of personalized medicine. This has contributed to the market’s expansion as precision medicine gains momentum.
The biotechnology sector is another major player in the PCR Molecular Diagnostics Market. Biotechnology firms use PCR for various applications such as research and development, genetic research, and product testing. With increasing investments in biotechnology, the demand for PCR-based diagnostic tools is anticipated to rise. Furthermore, the adoption of PCR for non-invasive prenatal testing (NIPT) has opened new market opportunities in reproductive health.
Industries involved in food safety and environmental testing also contribute to the growing demand for PCR. PCR-based techniques offer reliable ways to detect contaminants, pathogens, and genetically modified organisms (GMOs), making them indispensable in ensuring public health and safety.
In conclusion, the PCR Molecular Diagnostics Market in the US is experiencing rapid expansion across various sectors, driven by its accuracy, versatility, and critical role in diagnostic and research applications. As technology continues to advance, the market's demand is expected to rise, providing significant opportunities for growth and innovation in multiple industries.
Get an In-Depth Research Analysis of the US PCR Molecular Diagnostics Market Size And Forecast [2025-2032]
Â
Abbott Laboratories
bioMereieux SA
Danaher Corporation
Bio-Rad Laboratories
QIAGEN N.V
F-Hoffmann-La Roche Ltd.
Genomic Health
GRIFOLS S.A
Thermo Fisher Scientific Inc.
Seegene Inc.
Hologic Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US PCR Molecular Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US PCR Molecular Diagnostics Market
Reagents and Consumables
Instruments
Software and Services
Real-Time PCR (qPCR)
Digital PCR (dPCR)
Conventional PCR
Oncology Diagnostics
Infectious Disease Diagnostics
Genetic Testing
Blood Screening
Others
Hospitals and Clinics
Diagnostic Laboratories
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Blood Samples
Saliva Samples
Tissue Samples
Urine Samples
Others
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ PCR Molecular Diagnostics Market Research Analysis
1. Introduction of the US PCR Molecular Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US PCR Molecular Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US PCR Molecular Diagnostics Market, By Type
6. US PCR Molecular Diagnostics Market, By Application
7. US PCR Molecular Diagnostics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US PCR Molecular Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/